Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Sarcoma
•
Medical Oncology
What is your preferred second-line therapy for metastatic follicular dendritic cell sarcoma after progression on anthracycline-based chemotherapy?
Sarcoma arose from Castleman disease
Answer from: Medical Oncologist at Academic Institution
Gemcitabine plus a taxane has good reported activity with an RR of 80% - Jain et al., PMID 28382648.
Sign in or Register to read more
20155
Related Questions
What systemic treatment do you utilize for patients with metastatic fibrosarcomatous DFSP that have progressed on imatinib?
How do you approach patients with SDH deficient advanced GIST tumor for systemic treatment?
How would you approach patients with primary cardiac sarcomas for adjuvant systemic treatment?
How do you approach a well controlled HIV patient with diffuse cutaneous kaposi sarcoma who failed to respond to radiation, paclitaxel and monthly liposomal doxorubicin?
How do you approach patients with osteosarcoma of the maxilla for neoadjuvant chemotherapy?
How would you treat a patient with a locally recurrent myxofibrosarcoma, FNCLCC grade 2, that has recurred after multiple resections and radiotherapy?
How do you approach a young patient with undifferentiated pleomorphic sarcoma of the upper extremity who developed ifosfamide-induced nephrotoxicity after two cycles of adjuvant AIM chemotherapy?
How do you approach a patient with undifferentiated pleomorphic sarcoma encasing the spinal cord post radiation for neurological deficits for further management?
How do you sequence treatment for a patient following R2 resection of a large extremity leiomyosarcoma who has small lung nodules concerning for metastatic disease, but not yet biopsy proven?
When would you ever consider lifelong imatinib in adjuvant therapy for GIST?